XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS - Summary of Contingent Consideration Measured at Fair Value (Details) - Contingent Consideration
$ in Thousands
3 Months Ended
Dec. 31, 2023
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Beginning Balance $ 7,976
Expenses recorded due to changes in fair value 136
Cash payment of contingent consideration associated with the ID R&D acquisition (4,641)
Issuance of common stock as contingent consideration associated with the ID R&D acquisition (3,471)
Ending Balance $ 0